A. Scanni
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 5%
- Molecular Biology
- Surgery
- Co-authors
- M. TomirottiGabriella FarinaMarina Chiara GarassinoOlga MartelliRoberto LabiancaCalogero LauricellaMassimo BrogginiSilvia Marsoni
- Topics
- Cancer Treatment and Pharmacology (15 papers)Breast Cancer Treatment Studies (8 papers)Lung Cancer Treatments and Mutations (7 papers)
- Partner nations
- ItalyMalaysiaUnited States
In The Last Decade
A. Scanni
46 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 89
- Oncology 849
- Pulmonary and Respiratory Medicine 600
- Cancer Research 340
- Molecular Biology 151
- Surgery 129
Countries citing papers authored by A. Scanni
This map shows the geographic impact of A. Scanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Scanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Scanni more than expected).
Fields of papers citing papers by A. Scanni
This network shows the impact of papers produced by A. Scanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Scanni. The network helps show where A. Scanni may publish in the future.
Co-authorship network of co-authors of A. Scanni
This figure shows the co-authorship network connecting the top 25 collaborators of A. Scanni. A scholar is included among the top collaborators of A. Scanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Scanni. A. Scanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 73 | |
| 2 | Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trialbreakdown → | 376 |
| 3 | 13 | |
| 4 | 5 | |
| 5 | 57 | |
| 6 | 17 | |
| 7 | 5 | |
| 8 | 18 | |
| 9 | 4 | |
| 10 | 146 | |
| 11 | 5 | |
| 12 | 47 | |
| 13 | 99 | |
| 14 | 2 | |
| 15 | 10 | |
| 16 | 6 | |
| 17 | 34 | |
| 18 | 25 | |
| 19 | 81 | |
| 20 | 37 |
About A. Scanni
A. Scanni is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), Breast Cancer Treatment Studies (8 papers) and Lung Cancer Treatments and Mutations (7 papers). The work is most often cited by research in Oncology (849 citations), Cancer Research (340 citations) and Pulmonary and Respiratory Medicine (600 citations). A. Scanni has collaborated with scholars based in Italy, Malaysia and United States. Frequent co-authors include M. Tomirotti, Gabriella Farina, Marina Chiara Garassino, Olga Martelli, Roberto Labianca, Calogero Lauricella, Massimo Broggini, Silvia Marsoni, Flavia Longo and Silvio Veronese. Their work appears in journals such as Journal of Clinical Oncology, Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.